Recipients of the 2012 New Investigator Awards
This is the seventh year of competition for ATVB New Investigator Awards. The Awards recognize papers published in ATVB in 2011 that were submitted by new investigators and judged to be the most outstanding in the Atherosclerosis/Lipoprotein, Thrombosis, and Vascular Biology sections of the journal. The three awards are named for Dr Daniel Steinberg, who devised a method to determine the site of degradation of the proteins and lipids of a lipoprotein, which led to the concept of selective uptake of cholesterol and apoprotein that characterizes the reverse cholesterol transport pathway; Dr Karl Link, who identified dicoumarol as the hemorrhagic factor in spoiled sweet clover hay, and then developed dicoumarol and warfarin as anticoagulant drugs; and Dr Werner Risau, who formulated key concepts for the regulation of angiogenesis, challenged the prevailing dogmas about angiogenic factors, and proposed the now accepted hypothesis that several growth factors act sequentially to mediate vasculogenesis, angiogenesis, and vascular remodeling.
In the seventh year of the award, 622 papers were submitted for the Awards. Recipients of the awards are:
X. Long Zheng, MD, PhD, University of Pennsylvania, the 2011 recipient of the Karl Link New Investigator Award in Thrombosis, for his paper “Essential domains of ADAMTS13 metalloprotease required for modulation of arterial thrombosis” (Arterioscler Thromb Vasc Biol. 2011;31:2261–2269).
Kenji Nakajima, MD, PhD, Kobe University School of Medicine, the 2011 recipient of the Daniel Steinberg New Investigator Award in Atherosclerosis/Lipoproteins, for his paper “Orally administered eicosapentaenoic acid induces rapid regression of atherosclerosis via modulating the phenotype of dendritic cells in LDL receptor-deficient mice” (Arterioscler Thromb Vasc Biol. 2011;31:1963–1972).
Yajaira Suárez, PhD, New York University School of Medicine, the 2011 recipient of the Werner Risau New Investigator Award in Vascular Biology, for her paper “MicroRNA-16 and MicroRNA-424 regulate cell-autonomous angiogenic functions in endothelial cells via targeting VEGFR2 and FGFR1,” (Arterioscler Thromb Vasc Biol. 2011;31:2595–2606).
The recipients will be honored at the 13th Annual Conference on Atherosclerosis, Thrombosis and Vascular Biology and will receive a plaque, travel support (provided by the ATVB Council), and a check for $2500, provided by Lippincott, Williams and Wilkins.
The Editors congratulate the recipients of the Awards for their outstanding papers!
- © 2012 American Heart Association, Inc.